Seven biotech unicorns are advancing AI-powered drug discovery and development—but must contend with a difficult investing ...

Wayve was among the first unicorn AI startups in the UK, getting funding of over $1 billion for its self-driving artificial intelligence technology. The company is based in London and had its ...

Discover Grok 4, the AI model redefining advanced reasoning and problem-solving. Explore its potential, challenges, and ...

Below are the most-read DIGITIMES Asia stories from July 7 to July 13, 2025. This week's top three highlights include China’s ...

The biotechnology sector is hailing a major milestone as Isomorphic Labs, a startup incubated by Google DeepMind, prepares to enter human trials with a drug candidate designed using artificial ...

The start-up, which aims to raise tens of millions of US dollars in an angel funding round, hopes to compete globally, ...

Google DeepMind subsidiary, Isomorphic Labs, has said it is ready to conduct human trials for drugs developed using its AlphaFold AI technology.

Isomorphic Labs is preparing to test AI-designed drugs in humans, marking a new phase in drug development with artificial ...

Google Deepmind’s offshoot Isomorphic Labs is about to be a milestone: The first AI developed medication should go into the ...

The oncology drug created by Isomorphic Labs using Google DeepMind’s AlphaFold 3 tool could be pivotal for cancer treatment.

Isomorphic Labs, backed by Google's parent company Alphabet, is preparing for its first human clinical trials for cancer drugs designed entirely by artificial intelligence.

A secretive, Google-backed lab is using artificial intelligence to invent new medicines for humanity's worst illnesses. But ...